23
Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA

Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Understanding and Managing MMP’s in Wound Bed

Brock Liden DPM, ABPM, FAPWCA

Page 2: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Learning Objectives

• Review the four sequential phases of normal wound healing and recognize the BENEFICIAL effects of CONTROLLEDINFLAMMATION and PROTEASE ACTIVITIES

• Understand the link between CHRONIC INFLAMMATION caused by PLANKTONIC and BIOFILM BACTERIA and ELEVATEDPROTEASE ACTIVITIES that DESTROY proteins that are essential to healing (extracellular matrix, growth factors, receptors)

• Understand the VARIATION of proteases and their IMPACT on wound healing

• Discuss current approaches to MANAGMENT AND REMOVAL of proteases from the wound bed

Page 3: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Four Phases of Wound Healing

Schultz, G., Davidson, J., Kirsner, R., Bornstein, P., & Herman, I. (2011). Dynamic reciprocity in the wound microenvironment. Wound Repair and Regeneration, 19(2), 134-148.

Page 4: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Four Phases of Wound Healing

• Leukocyte migration

• Neutrophils

• Macrophages

• Release of growth factors

Inflammation

Controlled inflammation is beneficial

Schultz, G., Davidson, J., Kirsner, R., Bornstein, P., & Herman, I. (2011). Dynamic reciprocity in the wound microenvironment. Wound Repair and Regeneration, 19(2), 134-148.

Page 5: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Matrix Metalloproteinases - MMPs

Necessary for Wound Healing

P

P

P

P

P

PP

P P

P

PPP

P

Debridement Angiogenesis Contraction

Epithelial Migration Remodeling

Gibson, D., Cullen, B., Legerstee, R., Harding, K., & Schultz, G. (2009). MMP's made easy. Wounds International, 1(1). Retrieved from http://www.woundsinternational.com/made-easys/mmps-made-easy

Page 6: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

MMPs in Normal Wound Healing

MMPs are essential for normal wound healing, BUT must be:

• At the right places

• At the right times

• At the right amounts

Page 7: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Venous Leg Ulcers are Inflammatory

Beidler SK, et al. Multiplexed analysis of matrix metalloproteinases in leg ulcer tissue of patients with chronic venous insufficiency before and after compression therapy. Wound Repair Regen. 2008, 16(5)642-648. Beidler sK, et al. Inflammatory

cytokine levels in chronic venous insufficiency ulcer tissue before and after compression therapy. J Vasc Surg. 2009;49(4):1013-1020.

Relative MMP Levels in Healthy Tissue and Leg Ulcer Tissue

before and after Compression Therapy

Page 8: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Repeated

Tissue Injury

Ischemia

and

Bioburden-Biofilm

ProlongedElevated

Inflammation

↑Neutrophils

↑Macrophages

↑Mast cells

Destruction of

Essential Proteins

↑ECM degradation

↓Growth factors/receptors

↓Cell migration

↓Cell proliferation

ImbalancedProteases andInhibitors

↑Proteases

↓ Inhibitors

Chronic WoundPathophysiology

Mast, B., & Schultz, G. (1996). Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair and

Regeneration, 4(4), 411-420.

Page 9: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Elevated MMP-1 in Venous Ulcers

Beidler, S. K., Douillet, C. D., Berndt, D. F., Keagy, B. A., Rich, P. B., & Marston, W. A. (2008). Multiplexed analysis of matrix metalloproteinases in leg ulcer tissue of patients with chronic venous insufficiency

before and after compression therapy. Wound Repair and Regeneration, 16(5), 642-648.

Poor Healers

Intermediate Healers

Good Healers

Page 10: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Healing of Pressure Ulcers is Predicted by Protease Activity in Wound Fluids

0

50

100

150

200

250

300

350

400

450

Day-0 Day-10 Day-36

Time Course

Rati

o o

f M

MP

-9 (

pro

+ac

tiv

e):

TIM

P-1

(n

g/m

l)

Good Responders

Intermediate Responders

Poor Responders

Good Healing >95% area healed; n=12

Intermediate Healing <95% but >65% area healed; n=36

Poor Healing <65% area healed; n=8

Ladwig, Robson, Liu, Kuhn, Muir, Schultz.

Ratios of Activated MMP-9/TIMP-1 in Wound

Fluids Are Inversely Correlated With Healing

of Pressure Ulcers. Wound Rep Reg 26-37,

2002.

Page 11: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

MMPs in Diabetic Foot Wounds

Lobman, R., Ambrosch, A., Schultz, G., Waldmann, K., Schiweck, S., & Lehnert, H. (2002). Expression of matrix-metalloproteinases and their inhibitors in the wounds of

diabetic and non-diabetic patients. Diabetologia, 45(7), 1011-1016. doi: 10.1007/s00125-002-0868-8

Expression of MMP-1, MMP-9 and TIMP-2

Diabetic foot patients non-diabetic trauma patients

Page 12: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Sequential Degradation of the ECMChronic wounds typically show high levels of certain MMPs. These proteases sequentially degrade the native ECM, delaying healing.

Schultz GS, Mast, BA, Molecular Analysis of the Environments

of Healing and Chronic Wounds: Cytokines, Proteases, and

Growth Factors. Primary Intention. February 1999.

Page 13: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

MMP Wound Area Ratio

D. Gibson, Q. Yang, and G. Schultz. Description of MMP Activity Levels and Wound Surface Area Changes in Venous Leg Ulcers ,SAWC Spring, May 2-4, 2013 Denver, CO.

Page 14: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

0

20

40

60

80

100

120

0.00

2.00

4.00

6.00

8.00

10.00

12.00

14.00

16.00

18.00

0 10 20 30 40 50 60 70 80 90 100

% o

f A

rea

at F

irst

Pre

sen

tati

on

(%

)

rhM

MP

-9 E

qu

ival

en

t A

ctiv

ity

(µg/

ml)

Day Within Trial (day #)

MMP Time Line

Wound Area Time Line

MMP-9 Activity Correlates With Wound Healing Time Course

G. Bohn, B. Liden, G. Schultz, Q. Yang, D.J. Gibson. Ovine-Based Collagen Matrix Dressing: Next-

Generation Collagen Dressing for Wound Care. Advances Wound Care 6(1):1-6, 2016.

Page 15: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Biofilms Identified in >80% of Biopsies of Chronic

Wounds but in Only 6% of Acute Wounds

Panels A, B & C: G. James, E. Swogger, R. Wolcott, E. Pulcini, P. Secor, J. Sestrich, J. Costerton, P. Stewart. Wound Rep Regen, 16:37-44, 2008

Panel D: HC Flemming, J Wingender The Biofilm Matrix, Nature Rev Microbiol, 8:623-633, 2010

Panel E: SR Schooling , A Hubley, TJ Beveridge. J Bacteriol 191:4097-4012, 2009

M. Malone, T. Barjnsholt, A. McBain, G. James, P. Stoodley, D. Leaper, M. Tachi, G. Schultz, T. Swanson, R. Wolcott. Prevalence of biofilms in

chronic wounds: a systematic review and meta-analysis of published data, J wound Care, in press

DE

A CB

Page 16: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Question: How do biofilms impair healing of skin wounds?

Answer: Biofilms stimulate chronic

inflammation by increasing release of

proinflammatory cytokines which leads

to highly increased levels of proteases

and reactive oxygen species that

degrade proteins which are essential

for healing.

Page 17: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Effects of Antimicrobial Agents on Mature Biofilms on Pig Skin

Explants

P.L. Phillips, Q. Yang, E. Sampson, G. Schultz. Effects of Antimicrobial Agents on an In Vitro Biofilm Model of Skin Wounds, Advances

Wound Care, 1: 299-304, 2010.

24 hours of continuous exposure

Page 18: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Conclusion: Inflammation in chronic wounds must be reduced to levels that lead to low protease activities which will allow wounds to heal.

Action: Bacterial levels (both

planktonic and biofilm) must be

reduced for healing

Page 19: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Addressing MMP’s in the Wound Bed

• Debridement

• Sacrificial substrate

• Negative pressure

• Sponge effect

• Drugs

• Compression

• TIMP’s

• Themselves

Page 20: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Aggressive

debridement

Empirical

topics

antiseptics

and systemic

antibiotics

Manage host

factors (off-

loading,

compression,

diabetes,

nutrition)

~days 1–4

DNA

identification

of micro-

organisms and

point-of-care

diagnostics

Assess

inflammation

and healing

status

Appropriate

debridement

Optimize

/personalize

topical

antiseptics and

systemic ABX

~days 5–7

Continue

management of

host factors

Maintenance debridement

Re-evaluate need for topical

antiseptics and systemic antibiotics

~1–4 weeks

Continue management of host

factors

Initiate multiple

therapies in

combination

Optimize

personalize

therapy according

to healing status

De-escalate

treatment as

wound improves

Continue until healed

Step up to

advanced

therapies

Evaluate wound

healing and

decide

Assess inflammation and healing

status

Advanced

therapies:

• Growth factors

• Skin grafts

• Combination

productsStandard

care Standard care

Step-Down-Step-Up Treatment for Chronic Wounds

Page 21: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

New Research Confusing / Complicated

• A trial showed COLLAGEN may not reduce MMP activity

• In vitro proteinases rapidly lose activity, likely due AUTOLYSIS• Introduction of protein PROTECTS the proteinases and increase half-life

• Competitive inhibition via protein IS NOT supported by this study

• MMP activity CAN PREDICT FAILURE of progression week to week

• Proteinases are NOT THE ONLY source of failure

Page 22: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Conclusion

• Must address PLANKTONIC BACTERIA AND BIOFILM • Planktonic

• BIOFILM

• A severe impact of BIOFILM IS TO DRIVE PROTEASE ELEVATION• INFLAMATION

• UTILIZATION OF MULTIPLE modalities to lower MMP• COMBINATION THERAPIES

• Utilization of the STEP UP STEP DOWN treatment protocol

Page 23: Understanding and Managing MMP’s in Wound Bed and managing MMPs in woundcare... · Understanding and Managing MMP’s in Wound Bed Brock Liden DPM, ABPM, FAPWCA. Learning Objectives

Thank You